TOKYO – A Keio University research team will begin clinical tests for the treatment of amyotrophic lateral sclerosis (ALS), administering ALS patients an existing drug used for another disease, which is confirmed to be effective in experiments with induced pluripotent stem (iPS) cells. The researchers conducted experiments using iPS cells created from the cells of … Continue reading Japan university’s clinical tests to use Parkinson’s drug for ALS